• DAILY UPDATES
  • MARKETS
    • Forex
    • CFDs
    • Spot Metals
    • Indices
  • ANALYSIS
    • Fundamental Analysis
    • Technical Analysis
  • ARTICLES
No Result
View All Result
FTD Limited
  • DAILY UPDATES
  • MARKETS
    • Forex
    • CFDs
    • Spot Metals
    • Indices
  • ANALYSIS
    • Fundamental Analysis
    • Technical Analysis
  • ARTICLES
No Result
View All Result
FTD Limited
No Result
View All Result

Thursday, December 10, 2020 Headlines

FTD Limited by FTD Limited
December 10, 2020
Reading Time: 4 mins read
A A
Trump signs Covid-19 stimulus package; EU and UK agree on post-Brexit trade deal; Mass vaccination against coronavirus has officially started in the EU.
0
SHARES
38
VIEWS
tweetpostshare
  1. Hackers steal data on vaccine from BioNTech and Pfizer
  2. WHO experts arrive in India where an outbreak of an unknown disease has occurred
  3. Airbnb went public, now worth $47 billion
Hackers steal data on vaccine from BioNTech and Pfizer

Hackers Steal Data on Vaccine from BioNTech and Pfizer

On Wednesday, U.S. drugmaker Pfizer and its German partner BioNTech revealed that documents relating to their production of the Covid-19 vaccine were “unlawfully accessed” in a cyberattack against the European drug regulator.

The hackers who carried out the cyberattack on the European Medicines Agency (EMA) gained access to some documents about the coronavirus vaccine from pharmaceutical companies BioNTech and Pfizer.

On the eve it became known that the EMA was subjected to a cyberattack. It was reported that the agency promptly launched a full investigation in close cooperation with law enforcement agencies.

“We were informed by the European Medicines Agency (EMA) that the agency was under cyberattack and that some documents related to the regulatory submission of the BioNTech and Pfizer vaccine candidate that was stored on the EMA server were illegally obtained,” was stated on the BioNTech website.

There is no information yet on what the hackers intend to do with the information received. BioNTech said it is awaiting additional information about the investigation conducted by the EMA and is going to respond in accordance with EU legislation.

The EMA agency is responsible for studying the results of trials of vaccines against coronavirus, makes its conclusions, and recommends them for use in the pharmaceutical market of the European Union.

The German company BioNTech and the American pharmaceutical giant Pfizer previously announced a successful third phase of clinical trials of their own vaccine – it has shown efficiency of about 95% in preventing coronavirus infection.

WHO Experts Arrive in India Where an Outbreak of an Unknown Disease Has Occurred

Two experts from the WHO arrived in the Indian city of Eluru, where, according to the latest data, 593 people were affected by an unknown disease, according to the local tv channel Times Now.

An outbreak of an unknown disease in the city of Eluru and its surroundings began last Sunday. Symptoms include epileptic seizures within three to five minutes, memory loss within minutes, sudden fainting spells, headache, and back pain.

Earlier it was reported that teams of doctors from the National Institute of Nutrition, the Institute of Chemical Technology and the Indian Institute of Medical Sciences were sent to the city to determine the cause of the disease. Specialists test samples of blood, urine of patients, and also study food and water samples.

Earlier, the office of the chief minister of the state of Andhra Pradesh said that the cause of the mysterious disease could be lead and nickel poisoning, traces of which were found in water and milk. However, it was reported that these are preliminary data and it is necessary to wait for the results of additional studies.

Doctors in Eluru, the city where the diseases have been registered, told the Indian Express that in the past two days, the number of cases has decreased and patients have recovered rapidly. Experts from the World Health Organization are also on the field, alongside government teams. Door-to-door surveys have been requested to monitor people’s health issues as inquiries proceed into potential causes.

Airbnb Went Public, Now Worth $47 billion

Despite a pandemic that laid waste to most of the travel industry, Airbnb Inc. pulled off one of the biggest initial public offerings in 2020. Airbnb Inc. Earned $ 3.5 billion in public offering revenue, achieving a valuation above the price range set in the long-awaited public offering.

Airbnb sold 52 million shares for $ 68, which is above the targeted range. With the public offering, Airbnb was valued at $47 billion.

Although international travels dropped during the pandemic period, short-distance travel made Airbnb more durable than hotel chains. Airbnb revenue fell 18 percent in the third quarter, while Expedia and Marriott fell close to 60 percent.

The prices were reported on Wednesday evening by Bloomberg and Dow Jones, citing unnamed sources. Pricing will raise the value of Airbnb to about $47 billion. Such a level will mark a substantial increase following a pair of debt funding rounds from the company’s private valuation of about $18 billion in April, and its private pre-coronavirus valuation of $31 billion as of 2017.

With the Airbnb public offering, the size of the public offering on the US Stock Exchanges increased to 163 billion dollars. Shares of Airbnb are set to trade on the Nasdaq Thursday under the ticker “ABNB.”

Learn more about us

Tags: airbnb ipoBiontechIndian newsPfizer
TweetShareShareSend
Previous Post

Dow Jones Formed A Bearish Wedge Formation

Next Post

EURUSD, Ahead of ECB Decision

Related Posts

The Reserve Bank of Australia increased its policy rate by 50 basis points
DAILY UPDATES

The Reserve Bank of Australia Increased Its Policy Rate by 50 Basis Points

Yellen meets with Chinese Vice Premier
DAILY UPDATES

Yellen Meets With Chinese Vice Premier

Recession Warning From Bank of America
DAILY UPDATES

Recession Warning From Bank of America

Inflation in Switzerland at a 29-Year High
DAILY UPDATES

Inflation in Switzerland at a 29-Year High

Oil prices rise
DAILY UPDATES

Recession and Supply Concerns on Oil

Inflation in France
DAILY UPDATES

Inflation Hits Record in France

Next Post
Technical analysis article on EURUSD

EURUSD, Ahead of ECB Decision

You might also like

Psychology of trading plays a vital role in one's trading decisions

Trading Psychology

Differences between MT4 and Mt5

MT4 and MT5’s Differences – How to See the Total Lot Sizes in MT5?

Regulated and Licensed Forex Brokerage Company

Regulated Entities

FTD Limited's White Label Program gives you a chance to have your own brand within financial markets.

White Label Solutions

FTD Limited offers Introducing Brokers Program

Introducing Brokers

Algorithmic trading in forex, cfds and indices

Basics of Algorithmic Trading: Concepts and Strategies

Recent Posts

  • The Reserve Bank of Australia Increased Its Policy Rate by 50 Basis Points
  • Yellen Meets With Chinese Vice Premier
  • Recession Warning From Bank of America
  • Inflation in Switzerland at a 29-Year High
  • Recession and Supply Concerns on Oil
FTD Limited

The content of the site is presented for informational purposes only not to give any investment advice which mainly focuses on financial instruments such as Forex, Spot Metals, CFDs, and Indices.

MENU

  • DAILY UPDATES
  • MARKETS
  • ANALYSIS
  • ARTICLES

Latest Articles

  • The Reserve Bank of Australia Increased Its Policy Rate by 50 Basis Points
  • Yellen Meets With Chinese Vice Premier
  • Recession Warning From Bank of America

Subscribe to our newsletter and get notified about the next update.

    © 2021 FTD Limited

    FTD Articles is a website prepared by FTD Limited's research team. FTD Limited is an online brokerage company offering products of Forex, Spot Metals and CFDs.

    The ideas and the information shown here have no responsibility of any of the trading decisions made by the investors or the visitors of this site. Therefore, under no circumstances will FTD Limited nor FTD Articles be held responsible or liable in any way for any claims, damages, losses, costs or liabilities resulting or arising directly or indirectly from the use of website content. We recommend that you seek advice if you have not involved with trading before in order to prevent potential risks that may arise.

    No Result
    View All Result
    • DAILY UPDATES
    • MARKETS
      • Forex
      • CFDs
      • Spot Metals
      • Indices
    • ANALYSIS
      • Fundamental Analysis
      • Technical Analysis
    • ARTICLES

    © 2021 FTD Limited

    FTD Articles is a website prepared by FTD Limited's research team. FTD Limited is an online brokerage company offering products of Forex, Spot Metals and CFDs.

    The ideas and the information shown here have no responsibility of any of the trading decisions made by the investors or the visitors of this site. Therefore, under no circumstances will FTD Limited nor FTD Articles be held responsible or liable in any way for any claims, damages, losses, costs or liabilities resulting or arising directly or indirectly from the use of website content. We recommend that you seek advice if you have not involved with trading before in order to prevent potential risks that may arise.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.